TEGRETOL Drug Patent Profile
✉ Email this page to a colleague
When do Tegretol patents expire, and what generic alternatives are available?
Tegretol is a drug marketed by Novartis and is included in four NDAs.
The generic ingredient in TEGRETOL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tegretol
A generic version of TEGRETOL was approved as carbamazepine by TARO on October 3rd, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TEGRETOL?
- What are the global sales for TEGRETOL?
- What is Average Wholesale Price for TEGRETOL?
Summary for TEGRETOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 163 |
Clinical Trials: | 25 |
Patent Applications: | 2,956 |
Drug Prices: | Drug price information for TEGRETOL |
Drug Sales Revenues: | Drug sales revenues for TEGRETOL |
What excipients (inactive ingredients) are in TEGRETOL? | TEGRETOL excipients list |
DailyMed Link: | TEGRETOL at DailyMed |
US Patents and Regulatory Information for TEGRETOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | TEGRETOL | carbamazepine | SUSPENSION;ORAL | 018927-001 | Dec 18, 1987 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-001 | Mar 25, 1996 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novartis | TEGRETOL | carbamazepine | TABLET, CHEWABLE;ORAL | 018281-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Novartis | TEGRETOL | carbamazepine | TABLET;ORAL | 016608-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-003 | Mar 25, 1996 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Novartis | TEGRETOL-XR | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 020234-002 | Mar 25, 1996 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TEGRETOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | TEGRETOL | carbamazepine | SUSPENSION;ORAL | 018927-001 | Dec 18, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | TEGRETOL | carbamazepine | TABLET;ORAL | 016608-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | TEGRETOL | carbamazepine | TABLET, CHEWABLE;ORAL | 018281-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TEGRETOL
See the table below for patents covering TEGRETOL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Philippines | 17334 | METHOD OF PREVENTING AND TREATING CEREBRAL INSUFFICIENCY | ⤷ Sign Up |
Australia | 8263382 | ⤷ Sign Up | |
Italy | 8248224 | ⤷ Sign Up | |
Italy | 1147841 | PREPARATI FARMACEUTICI PER LA PROFILASSI ED IL TRATTAMENTO DI INSUFFICIENZA DI RENDIMENTO CEREBRALE | ⤷ Sign Up |
Switzerland | 649080 | 5H-DIBENZ(B,F)AZEPIN-5-CARBOXAMIDE ALS MITTEL ZUR PROPHYLAXE UND BEHANDLUNG VON ZEREBRALER LEISTUNGSINSUFFIZIENZ. | ⤷ Sign Up |
Belgium | 892882 | ⤷ Sign Up | |
Japan | S57181013 | PHARMACOLOGICAL COMPOSITION FOR PREVENTION AND TREATMENT OF CEREBRAL INSUFFICIENCY | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |